{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:20:28Z","timestamp":1783088428836,"version":"3.54.6"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clinical guidelines are intended to improve the quality of medical care. The aim of this survey was to record the concrete implementation of guidelines in practice and criteria for their implementation in Germany.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Using a web-based questionnaire developed with medical scientific societies and uzbonn, general practitioners were able to participate anonymously in the survey between July 1, 2024, and October 31, 2024. Data were statistically evaluated using descriptive methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four hundred thirty-seven physicians participated in the survey. 74.1% frequently implement guideline recommendations, 13.3% always, 11.2% rarely, and 1.4% never. 67.3% consider the guidelines to be too extensive. 71.6% regularly inform themselves about guideline updates. Motivators include a high recommendation rate (86.4%), recommending scientific society (78.7%), and discussion in medical training events (85.6%). The highest attention is given to National Care Guidelines (Nationale VersorgungsLeitlinie, NVL) 71.2% and guidelines of national scientific societies (65.4%). Barriers include the extent (67.3%), lack of practical relevance (51.5%), time required (47.2%), differing recommendations between various guidelines (46%), and uncertainty about validity (45.9%). Supportive measures would be a summary of essential content (98%), pocket guidelines from scientific societies (84.2%), discussions in quality circles (76.4%), and brief information in German medical journals (73.2%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Clinical guideline recommendations are highly accepted in everyday practice, especially the German NVL. The extent, lack of practical relevance, time required, discrepancies in recommendations, and differences in validity are significant barriers. Summaries of essential recommendations, pocket guidelines, and regular publications in medical journals could help increase application of clinical guidelines in practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1852365","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:37:46Z","timestamp":1783085866000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of clinical guideline implementations for cardiovascular diseases by German general practitioners\u2014Results of a web-based survey"],"prefix":"10.3389","volume":"13","author":[{"given":"Markus","family":"van der Giet","sequence":"first","affiliation":[{"name":"Charit\u00e9 Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Schwaab","sequence":"additional","affiliation":[{"name":"Curschmann Klinik, GmbH & Co. KG, Timmendorfer Strand","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Mayerb\u00f6ck","sequence":"additional","affiliation":[{"name":"uzbonn \u2013 Gesellschaft f\u00fcr empirische Sozialforschung und Evaluation, Bonn","place":["Bonn, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Klein","sequence":"additional","affiliation":[{"name":"uzbonn \u2013 Gesellschaft f\u00fcr empirische Sozialforschung und Evaluation, Bonn","place":["Bonn, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Randerath","sequence":"additional","affiliation":[{"name":"APONTIS PHARMA Deutschland GmbH & Co. KG, Medizin","place":["Monheim, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Weing\u00e4rtner","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum Jena, Klinik f\u00fcr Innere Medizin I","place":["Jena, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.17226\/1626","volume-title":"Clinical Practice Guidelines \u2013 Directions for a New Program","author":"Field","year":"1990"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/jehp.jehp_426_19","article-title":"Management of arterial hypertension: transfer from clinical guidelines into daily practice \u2013 results of a survey in German practitioner\u2019s offices","volume":"9","author":"Predel","year":"2020","journal-title":"J Edu Health Promot"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40292-025-00750-9","article-title":"Prevalence and medical treatment of arterial hypertension and hypercholesterolemia in Germany: a nationwide questionnaire-based survey in medical practices","volume":"33","author":"Beger","year":"2026","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2165901","DOI":"10.1080\/08037051.2023.2165901","article-title":"Current practice of blood pressure measurement in Germany: a nationwide questionnaire-based survey in medical practices","volume":"32","author":"Beger","year":"2023","journal-title":"Blood Press"},{"key":"ref5","first-page":"32","article-title":"Pr\u00e4diktoren f\u00fcr eine leitliniengerechte Therapie in der Sekund\u00e4rpr\u00e4vention kardiovaskul\u00e4rer Ereignisse \u2013 Ergebnisse einer retrospektiven Datenanalyse","volume":"165","author":"Wilke","year":"2023","journal-title":"MMW"},{"key":"ref6","first-page":"19","article-title":"H\u00e4ufigkeit von Bluthochdruck, Dyslipid\u00e4mie und Typ 2 Diabetes bei Patienten mit kardiovaskul\u00e4ren Ereignissen \u2013 Ergebnisse der retrospektiven Datenanalyse einer deutschen Krankenversicherung","volume":"165","author":"Maywald","year":"2023","journal-title":"MMW"},{"key":"ref7","first-page":"29","article-title":"Medikament\u00f6se Sekund\u00e4rprophylaxe kardiovaskul\u00e4rer Ereignisse \u2013 Umsetzung von Leitlinien-empfohlener Medikation in der Hausarztpraxis","volume":"165","author":"Weisser","year":"2023","journal-title":"MMW"},{"key":"ref8","first-page":"21","article-title":"Ereignisraten bei unterschiedlicher Umsetzung von Leitlinien-empfohlener Medikation zur Sekund\u00e4rprophylaxe kardiovaskul\u00e4rer Ereignisse in der Hausarztpraxis","volume":"165","author":"Predel","year":"2023","journal-title":"MMW"},{"key":"ref9","first-page":"28","article-title":"Einsatz von ASS in der Sekund\u00e4rpr\u00e4vention kardiovaskul\u00e4rer Ereignisse in deutschen Hausarztpraxen\u2013 Ergebnisse einer retrospektiven Datenanalyse","volume":"165","author":"Wa\u00dfmann","year":"2023","journal-title":"MMW"},{"key":"ref10","volume-title":"Versorgungs-Report. Leitlinien \u2013 Evidenz f\u00fcr die Praxis","author":"van Gassen","year":"2023"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.mayocpiqo.2020.09.016","article-title":"Financial conflicts of interest in clinical practice guidelines: a systematic review","volume":"5","author":"Tabatabavakili","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.7326\/0003-4819-152-11-201006010-00254","article-title":"The vexing problem of guidelines and conflict of interest: a potential solution","volume":"152","author":"Guyatt","year":"2019","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.7861\/clinmed.2020-0552","article-title":"Analysis of conflicts of interest among authors and researchers of European clinical guidelines in cardiovascular medicine","volume":"21","author":"Hinton","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2215\/CJN.04640422","article-title":"Conflicts of interest and the trustworthiness of clinical practice guidelines","volume":"17","author":"Mathew","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12181-025-00744-w","article-title":"Stellungnahme zur kritischen Bewertung der Nationalen VersorgungsLeitlinie zur chronischen koronaren Herzerkrankung","volume":"19","author":"Mehilli","year":"2025","journal-title":"Kardiologie"},{"key":"ref16","volume-title":"Umsetzung von Leitlinien \u2013 hinderliche und f\u00f6rderliche Faktoren. Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen. Report \u2013 Nr. 389","year":"2016"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.2196\/jmir.5.2.e12","article-title":"Use of the world wide web to implement clinical practice guidelines: a feasibility study","volume":"5","author":"Jeannot","year":"2003","journal-title":"J Med Internet Res"},{"key":"ref18","year":"2023"},{"key":"ref19","year":"2025"},{"key":"ref20","year":"2025"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/ANS.0000000000000263","article-title":"Implementation of clinical practice guidelines in the health care setting: a concept analysis","volume":"42","author":"Beauchemin","year":"2019","journal-title":"ANS Adv Nurs Sci"},{"key":"ref22","year":"2025"},{"key":"ref23","first-page":"A1215","article-title":"Heart disease in Germany. Leading cause of death","year":"2024"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1852365\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:37:47Z","timestamp":1783085867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1852365\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":23,"alternative-id":["10.3389\/fmed.2026.1852365"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1852365","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"article-number":"1852365"}}